Q1 2025 Holdings
Filed 2025-05-14 | 69 holdings | $489.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $34.7M | 545,872 | 7.1% |
| Merus N V | COM | N5749R100 | $34.1M | 811,021 | 7.0% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $31.1M | 439,018 | 6.4% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $29.1M | 719,992 | 6.0% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $24.5M | 321,366 | 5.0% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $19.6M | 1,698,984 | 4.0% |
| Veracyte Inc(VCYT) | COM | 92337F107 | $18.8M | 633,832 | 3.8% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $17.9M | 337,605 | 3.7% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $16.1M | 1,309,224 | 3.3% |
| Urogen Pharma LTD(URGN) | COM | M96088105 | $15.3M | 1,381,158 | 3.1% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $12.1M | 411,312 | 2.5% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $11.9M | 166,417 | 2.4% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $11.8M | 75,751 | 2.4% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $11.7M | 236,471 | 2.4% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $11.5M | 2,060,240 | 2.4% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $11.0M | 1,510,498 | 2.2% |
| Erasca Inc(ERAS) | COM | 29479A108 | $10.1M | 7,367,996 | 2.1% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $8.5M | 1,050,374 | 1.7% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $8.0M | 72,583 | 1.6% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $7.3M | 408,849 | 1.5% |
| Akero Therapeutics IncCall | CALL | 00973Y908 | $7.3M | 180,600 | 1.5% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $7.0M | 6,320,684 | 1.4% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $7.0M | 62,029 | 1.4% |
| Helix Acquisition Corp II | CL A ORD SHS | G4444H101 | $6.9M | 613,393 | 1.4% |
| Elutia Inc(ELUT) | CL A COM | 05479K106 | $6.8M | 2,670,056 | 1.4% |
| Praxis Precision Medicines I(PRAX) | COM NEW | 74006W207 | $6.3M | 166,074 | 1.3% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $5.4M | 338,354 | 1.1% |
| Compugen LTD(CGEN) | ORD | M25722105 | $4.2M | 2,895,430 | 0.9% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $4.2M | 81,331 | 0.9% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $4.1M | 124,871 | 0.8% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $4.0M | 551,570 | 0.8% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $3.8M | 111,000 | 0.8% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $3.8M | 581,369 | 0.8% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $3.7M | 205,962 | 0.8% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $3.5M | 190,334 | 0.7% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $3.4M | 10,344 | 0.7% |
| Cerus Corp(CERS) | COM | 157085101 | $3.4M | 2,456,537 | 0.7% |
| Tela BIO Inc(TELA) | COM | 872381108 | $3.4M | 2,771,288 | 0.7% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $3.3M | 232,758 | 0.7% |
| Trevi Therapeutics Inc(TRVI) | COM | 89532M101 | $3.3M | 530,000 | 0.7% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $3.3M | 37,345 | 0.7% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $3.3M | 188,069 | 0.7% |
| Benitec Biopharma Inc(BNTC) | COM NEW | 08205P209 | $3.3M | 250,000 | 0.7% |
| Liquidia Corporation(LQDA) | COM NEW | 53635D202 | $3.2M | 214,057 | 0.6% |
| PTC Therapeutics Inc(PTCT) | COM | 69366J200 | $3.1M | 60,389 | 0.6% |
| Metsera Inc | COM | 59267L107 | $3.1M | 112,759 | 0.6% |
| Soleno Therapeutics IncPut | PUT | 834203959 | $3.0M | 42,500 | 0.6% |
| Biodesix Inc | COM | 09075X108 | $2.6M | 4,098,406 | 0.5% |
| Delcath SYS Inc(DCTH) | COM NEW | 24661P807 | $2.4M | 191,470 | 0.5% |
| Uniqure NV(QURE) | SHS | N90064101 | $2.2M | 203,400 | 0.4% |